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INTRODUCTION 
Pain is perhaps the most feared symptom of disease, which a man is always 
trying to alleviate and conquer since ages. Historically, children have been 
undertreated for pain and for painful procedures and are often unrecognized or 
neglected1. 
The International Association for the Study of Pain defines pain as “an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage.2 In children, even the 
definition of pain has been debated.3 Research over the past two decades has 
provided incontrovertible evidence that not only do neonates experience pain, but 
that unrelieved pain has adverse long-term consequences. They are harmful 
neuroendocrine responses, behavioral changes, disrupted eating and sleep cycles, 
and increased pain perception during subsequent painful experiences.4, 5, 6 
Till date, various methods and medications have been tried to provide post 
operative pain relief in pediatric population. Side effects of the pain medication 
have limited their use in children. For example, narcotics could cause respiratory 
depression, pruritis. Oral analgesics cannot be given during immediate post-
operative period after general anesthesia due to the risk of vomiting and aspiration. 
Fear of needle stick in the case of parenteral analgesics poses problem in pediatric 
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population. Pain management is an integral part of practice of pediatric 
anesthesiologists7. 
Regional anesthesia in pediatric population is safe and effective. Along with 
providing post-operative analgesia, it reduces requirements of inhalational and 
intravenous agents with minimum sedation 7. Caudal epidural anesthesia is the 
most commonly practiced regional technique in children for abdominal and lower 
limb surgeries. 
Many local anesthetic drugs of variable concentration are used. Bupivacaine 
is a long-acting amide local anaesthetic that has provided reliable anaesthesia and 
analgesia with differential motor-sensory blockade for more than 40 years.8, 9 
But the mean duration of surgical analgesia provided by long acting local 
anesthetic drug is only for 4-8 hrs during single shot caudal procedure. For this 
reason prolongation is achieved by addition of various adjuvants like opioids, 
clonidine, midazolam etc. Caudal opioid have advantages of prolonging duration 
of analgesia, but has side effects such as nausea, vomiting, pruritis and late 
respiratory depression10. 
Hence here is an attempt to study, addition of dexmedetomidine with 
striking lack of respiratory depressant effect, when given as adjuvant with caudal 
bupivacaine 8, 9. 
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AIM OF THE STUDY 
 This study aims to compare plain bupivacaine and dexmedetomidine as 
adjuvant to bupivacaine in prolongation of post operative analgesia in pediatric 
caudal anesthesia. 
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The posterior surface is rough and has greater interest for the anaesthetist. It 
is convex and in the midline runs a bony ridge, the median sacral crest with three 
or four rudimentary spinous processes. The fused vertebral arches forms the roof of 
the sacral canal 
The Sacral hiatus is a deficiency of posterior wall resulting from failure of 
fusion of the lamina of the fifth sacral vertebra that communicates with the sacral 
portion of the vertebral canal. This hiatus is triangular in shape with its apex at the 
spine of fourth sacral vertebra. 
In surface marking, it normally forms an approximately equilateral triangle 
with the two posterior superior iliac spines. There are bony prominences on the 
lateral margins of the space – the sacral   cornua – which represent the inferior 
articular processes of the fifth sacral vertebra. The base of the hiatus is the superior 
surface of the coccyx. The posterior sacrococcygeal ligament, a continuation of the 
ligamentum flavum, is attached to the bony margin and covers the hiatus. 
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 In some cases the apex of the hiatus is the third sacral spine, due to the 
absence of the third and fourth laminae, and occasionally the whole of the bony 
posterior wall is deficient. When the lamina of the fifth sacral vertebra is present, 
the hiatus may be very small with a diameter as narrow as 2mm making the 
introduction of a caudal needle almost impossible. 
There are four pairs of posterior sacral foramina corresponding with the 
anterior ones. The sacral canal is triangular and is the continuation of the epidural 
space and the dural sac, which usually terminates at the lower border of the second 
sacral vertebra though occasionally it extends below this point. The caudal epidural 
space contains the sacral and coccygeal nerve roots and filum terminale and 
continuation of the epidural venous plexus. Fibrous bands may be present in the 
sacral epidural space dividing it into loculi which prevent the spread of local 
anesthetic solutions and may result in incomplete anaesthesia. 
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PHYSIOLOGICAL EFFECTS: 11 
Local anaesthetic administered into the epidural space blocks nerve 
conduction. Extent to which the drug causes nerve conduction block is determined 
by concentration and volume of the drug injected, sensitivity of different nerve 
fiber types and by the drug employed. Although all agents tend to block 
preganglionic B fibers more readily, followed by pain fibers, the order of blocked 
are touch, proprioception and motor fibers because of difference in the selectivity 
for different sensory fibers. However muscle relaxation is a usual feature, muscle 
tone being reduced by the loss of afferent side of the reflex arc even in the 
presence of good voluntary power. 
Epidural administration of local anaesthetics produces regional effects, the 
distribution and extent of which are determined by the site and volume of injection. 
Local anaesthetics in epidural space act on the nerves as they traverse the epidural 
space or as they pass out through the intervertebral foramina into the paravertebral 
spaces or on the nerves in the subarachnoid space by diffusion through the dura. 
Among these the predominant site of action is in the region of the intervertebral 
foramina where the spinal nerves lose their protective dural sheaths. 
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Effects on Cardiovascular system:  
The effects of caudal block on the cardiovascular system are minimal except in 
cases of high caudal block. The blood pressure falls are not significant, and they 
can be treated with vasopressor drugs. There is usually slowing of the pulse. 
Effect on Respiratory system:  
Respiration is usually not affected by caudal anaesthetization. When high caudal 
block is affected, there is little evidence of paralysis of intercostal muscles. 
Effect on Gastrointestinal system: Caudal analgesia results in increased 
gastrointestinal tone that results in contracted bowel. 
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The first double bony protruberances encountered are the two cornua of 
sacrum that define the sacral hiatus. The cornua should be marked either mentally 
or with the skin marking pen. The sacral hiatus can also be identified by drawing 
an equilateral triangle with the line joining the two posterior superior iliac spines 
forming the base and the sacral hiatus forming the apex. 
After careful skin preparation, the sacral hiatus is again identified using firm 
pressure by the left index finger. Strict aseptic precautions should be maintained. A 
short beveled 23 gauge needle, preferably Crawford needle, is placed in the 
midline in the notch between the sacral cornua at an angle of about 45 with the 
skin (first position) and directed cranial, to penetrate the sacrococcygeal ligament, 
at which time contact is made with the anterior bony wall of the caudal 
canal(second position).  
The needle then is depressed almost flush with the skin and then advanced 
into the sacral canal. The advancement should not be higher than a line joining the 
posterior superior iliac spines (S2 vertebra) since the dural sac ends between the 
first and second sacral vertebrae in majority of patients. Auscultation of sound over 
the caudal canal by injecting air (Oosh) or drug (Swoosh) can be done to confirm 
the presence of the needle in the caudal space.  After negative aspiration for blood 
or cerebrospinal fluid, the appropriate amount of local anesthetic is injected and the 
child is placed in supine position. 
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CALCULATION OF VOLUME OF LOCAL ANAESTHETIC FOR 
CAUDAL ANAESTHESIA: 
¾ Armitage formula:13 
Sacral dermatomes – 0.5ml/kg, 
Sacral and lumbar – 1ml/kg 
Midthoracic – 1.25ml/kg 
¾ Spiegel formula:14 
For upper abdominal surgery,   V= 4+ D-15/2 
Where V is the volume of local anesthetic in milliliters and D is the distance 
between C7 and the sacral hiatus in centimeters. 
¾ Satayoshi formula:15 
V= D-13 
Where V is the volume of local anesthetic in milliliters and D is the distance 
from C7 to the sacral hiatus in centimeters. 
¾ Schulte-Scheinberg and Rahlfs formula:16 
Volume in ml /spinal segment = 0.0558+ 0.09729(age in years) 
¾ Takasaki formula:17 
Volume in ml / spinal segment = 0.056 (body weight in kg) - 0.002 
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PHYSIOLOGY OF PAIN 
Pain is a complex constellation of unpleasant sensory, perceptual and 
emotional experiences and certain associated autonomic, psychological, emotional, 
and behavioral responses. Untreated pain in children, as the result of vaccinations 
and blood draws, surgery, headaches or repeated painful procedures, can have 
long-term effects.18 
NEUROPHYSIOLOGY OF PAIN: 19 
A variety of chemical, thermal or mechanical insults can result in the 
sensation of pain. A mosaic of pain receptors or nociceptors in the body tissues 
ultimately project to pain centers in the brain. The somatosensory system is 
subserved by different groups of afferent fibers differentiated by their anatomy, 
rate of transmission, and sensory modality transmitted. The afferent fibers that 
relay pain information to the dorsal horn of the spinal cord and then on to the brain 
include small-diameter C-fibers and thinly myelinated A-delta fibers. 
The dorsal horn if organized into fairly discrete lamellae. The primary 
afferent first-order synapses (nociceptive-specific neurons) are located in layers 1, 
2 and 5 of the dorsal horn. Signals are then relayed rostrally to the thalamus and 
the cortex. In addition, afferent impulses are carried to the brainstem, limbic 
system, and hypothalamus to mediate many of the autonomic and affective 
14 
 
component responses to noxious stimuli. Deeper in the dorsal horn are located 
wide dynamic range neurons (WDR) that appear to be important in the 
development of hyperalgesia, or wind-up phenomenon. These neurons may be 
responsible for firing in pain syndromes that are not associated with obvious 
tissue-damage as well. 
DEVELOPMENTAL NEUROBIOLOGY OF PAIN: 
Nociceptive pathways in the periphery, spinal cord, and brain develop in a 
series of stages through the second and third trimester in humans. By 26 weeks` 
postconceptual age there is sufficient maturation of peripheral and spinal afferent 
transmission for the late-gestation fetus or preterm neonate to respond to tissue 
injury or inflammation with withdrawal reflexes, autonomic arousal and hormonal-
metabolic stress responses. There are also changes in responsiveness after injury or 
repetitive stimulation indicative of central sensitization.20 
It is important to understand that pain due to surgical procedures not only 
results in an immediate nociceptive response but also results in changes in the 
nociceptive activation pathways that lead to hypersensitivity, hyperalgesia and 
allodynia.21, 22 
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ASSESSMENT OF PAIN: 
SELF-REPORTING TECHNIQUES: 
¾ Visual analog pain scale (VAS):24 
It is often considered to be the gold standard for pain assessment. It is a 10cm 
horizontal line defined by “no pain” on the left end and “severe pain” on the right. 
It is used in older children and adolescents. The patient slides the cursor along the 
ruler until it reaches the level that represents the intensity of his pain. The other 
side of the ruler is graduated over 10mm and gives the investigator a numerical 
measure of pain. In children, the Verbal analog scale30 (pain rated from 0(no pain) 
to 10 (most pain possible) may be more reliable. 
¾ Analogue Chromatic Continuous Scale (ACCS):25 
The VAS has been modified for smaller children to equate pain intensity with 
colours in this scale. Instead of a line, the patient`s side of the scale is a wide band 
of colour ranging from pink for no pain to dark red for maximum pain, with 
increasing shades of red for intermediate degrees of pain. 
¾ Bieri – Modified:26,27 
This has Line drawings of faces from neutral to crying. This is mainly used for > 3 
years children and has score from 0 -6 (original), 0 -5 or -10 (modified). 
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¾ OUCHER Scale: (Beyer)28  
 It is used in 3-12 years children. This up and down scale has photographs of a 
child in six increasing degrees of pain scored from 0 for the comfortable and calm 
face to 100 for the upset crying face. 
BEHAVIOURAL AND COMPOSITE PAIN ASSESSMENT SCALES: 
¾ Premature Infant Pain Profile (PIPP):29,30 
This is mainly used for Preterm and full-term neonates. Gestational age, behavioral 
state, heart rate, oxygen saturation, brow bulge, eye squeeze, nasolabial furrow are 
the indicators. It has 0 – 21 scoring. 
¾ Neonatal Infant Pain Scale (NIPS):31 
This is based on facial expression, cry, breathing pattern, arms, legs, state of 
arousal. It is mainly used for Preterm and full-term infants. It has 0-10 score. 
¾ CRIES:32 
Crying, O2 saturation, Increased vital signs (Heart rate, Blood pressure), 
Expression and Sleeplessness are assessed in this scale. It is used in Full-term 
neonates and has a 0- 10 score. 
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¾ FLACC:23 
This is mainly used in 2 months to 7 years children. Facial expression, Legs, 
Activity state, Crying, Consolability is the indicators used here. It has 0 -10 score. 
FLACC scoring provides simple framework to quantify pain in children who may 
not able to verbalize the presence or severity of pain.   It is validated for the 
assessment of pain secondary to surgery, trauma, cancer, or other painful 
procedures for all preverbal children and children with mild to moderate cognitive 
impairment. 
 Interpretation FLACC behavioral scoring system: 
Each category is scored 0-2 on the scale. Which results in a total score of 0-10 
0 = relaxed and comfortable 
1-3 = mild discomfort mild pain 
4-6 = moderate discomfort or pain 
7-10= sever pain or discomfort  
¾ Children`s Hospital of Eastern Ontario Pain Scale (CHEOPS):33  
Cry, Facial expression, verbalization, torso position, touch (affected area); Legs are 
scored in this scale. It is used in 1-7 year age group. It has 4-13 scoring system. 
18 
 
¾ COMFORT Score:34 
It is applicable for all ages. The indicators assessed are alertness, 
calmness/agitation, respiratory response, physical movements, heart rate, blood 
pressure, muscle tone, facial tension. It has 0 -40 score. 
¾ Hannallah Objective Pain Scale: 35 . 
It uses six parameters like Systolic blood pressure, Crying, Movement, Agitation, 
Posture and Verbalization of pain. It is scored from 0 – 12. 
PHYSIOLOGICAL MEASURES: 
Observing changes in vital signs such as heart rate, blood pressure, 
respiration, oxygen saturation and sweating caused by pain removes the 
subjectivity of behavioral pain scoring methods, but these parameters may reflect 
changes for reasons other than pain and hence not often used. 
  
19 
 
PHARMACOLOGY OF BUPIVACAINE36 
HISTORY 
It is an amide linked local anesthetic synthesized by B.A.F. Ekenstam in 
1957 and introduced into clinical practice by Talivuo in 1963.  
CHEMICAL STRUCTURE: 36 
 
An amino amide local anesthetic having a benzene ring (lipophilic) at one 
end linked by an amide group to a tertiary amine (hydrophilic) on the other end of 
the molecule. It belongs to the group of pipecoloxylidide local anaethetics. All 
drugs in this group like mepivacaine, ropivacaine, levobupivacaine possess 
chirality due to the asymmetric carbon atom so that they may have optical isomers 
(enantiomers). The enantiomers may vary in their pharmacokinetics, 
pharmacodynamics and toxicity. Hence, administering a racemic drug mixture is, 
in reality, administration of two different drugs.37 Bupivacaine is available as a 
racemic mixture with the S-enantiomer less toxic than the R form.  
20 
 
 MECHANISM OF ACTION: 
 
Local anaesthetics prevent transmission of nerve impulses (conduction 
blockade) by inhibiting passage of sodium ions through ion-selective sodium 
channels in nerve membranes.36 they diffuse in their uncharged base form through 
neural sheaths and the axonal membrane to the internal surface of cell membrane 
sodium ion channels. They combine with hydrogen ions to form a cationic species 
which enters the internal opening of the sodium ion channel and binds with the 
channel in the inactivated-closed state. This produces blockade of sodium ion 
channel thereby decreasing sodium ion permeability and preventing depolarization 
of the cell membrane. 
21 
 
Binding affinities of local anaesthetics to the sodium ion channels are 
stereospecific thereby contributing to their differing potencies among the 
enantiomers. In addition to sodium ion channels, local anaesthetics block voltage-
dependent potassium channels but with lower affinity. Other additional actions 
may include blockade of voltage-dependent calcium ion channels (L-type most 
sensitive) and their action on G-protein coupled receptors.39 
Differential conduction blockade is illustrated by selective blockade of small 
C fibers and small- and medium-sized A fibers, with loss of pain and temperature 
and preservation of touch, proprioception and motor function at low concentrations 
of local anaesthetics. 
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PHARMACOKINETICS:36 
The onset and duration of conduction blockade is related to the pKa, lipid 
solubility and extent of protein binding of the drug. A low pKa and high lipid 
solubility are associated with a long duration of action. Pka of bupivacaine is 8.1, 
lipid solubility is 95%. 
ABSORPTION 
The absorption of bupivacaine from its site of injection into the systemic 
circulation is influenced by the site of injection and dosage and use of epinephrine 
but the ultimate plasma concentration is determined by the rate of tissue 
distribution and the rate of clearance of the drug. Lipid solubility is important in 
the tissue redistribution as well as being a primary determinant of the drug potency 
with bupivacaine being highly lipid soluble and more potent. Protein binding will 
also influence its distribution and excretion that parallels the lipid solubility and is 
inversely related to its plasma concentration. 
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PHARMACOKINETICS 
Elimination half life  210 min 
Volume of distribution (Vdss)  73 L 
Clearance (l/min)  0.47 
Toxic plasma concentration >3 micrograms/ml 
Table 1 
BIODEGRADATION AND ELIMINATION 
Liver is the site of metabolism. Two major factors controlling the clearance 
of the amide linked local anesthetics are hepatic blood flow and hepatic function. 
The principal pathways are N-dealkylation, aromatic hydroxylation, amide 
hydrolysis and conjugation.  
The mean total urinary excretion of bupivacaine and its dealkylation and 
hydroxylation metabolites account for >40% of the total anaesthetic dose. Alpha1 
acid glycoprotein is the most important plasma protein binding site of bupivacaine. 
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CLINICAL CHARACTERISTICS OF BUPIVACAINE36 
Clinical use Concentration Onset Duration (min) 
Infiltration 0.25% Fast 120-480 
Nerve block 0.25-0.5% Slow 240-960 
Epidural 0.5-0.75% Moderate 120-300 
Spinal 0.5-0.75% Fast 60-240 
Table 2 
Maximal dose 2mg/kg body weight 
ADVERSE EFFECT AND COMPLICATIONS 
Systemic toxicity: 
This is due to an excess plasma concentration of the drug. Plasma 
concentrations are determined by the rate of drug entrance into the systemic 
circulation relative to their redistribution to inactive tissue sites and clearance by 
metabolism. The magnitude of the toxicity depends on dose administered, 
vascularity of the injection site, presence of epinephrine in the solution and the 
protein binding of bupivacaine. 
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Central Nervous System 
Circumoral numbness is often an early symptom with restlessness, vertigo, 
tinnitus, and difficulty in focusing developing later. Further increases in the CNS 
concentration result in slurred speech and skeletal muscle twitching which signals 
the imminence of tonic-Clonic seizures. Seizures are classically followed by CNS 
depression, which may be accompanied by hypotension and apnea. The typical 
plasma concentration of bupivacaine associated with seizures is 4.5-5.5mic/ml. 
Hypoxia, Hypocarbia, hyperkalemia and acidosis can decrease the seizure 
threshold and increase CNS toxicity. The treatment includes oxygenation, 
ventilation and benzodiazepine or barbiturates help in termination of the seizures. 
Cardiovascular system 
The cardiovascular system is more resistant to the toxic effects of high 
plasma concentrations than is the CNS. Cardiac toxicity that results from high 
plasma concentrations occurs because; it blocks the inactivated state of the cardiac 
sodium and potassium (hKv1.5) channels40. The primary cardiac 
electrophysiologic effect of local anesthetics is a decrease in the rate of 
depolarization in the fast conducting tissues of Purkinje fibers and ventricular 
muscle.40 Action potential and the effective refractory period are also decreased by 
local anesthetics. 
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Accidental intravenous injection of bupivacaine may result in precipitous 
hypotension, cardiac dysrythmias like premature ventricular contractions, 
Supraventricular tachycardia, atrioventricular heart block and Ventricular 
tachycardia that may be resistant to conventional resuscitative measures. 
Cardiotoxic plasma concentrations are 8-10 mic/ml.41 
Moreover, bupivacaine depress the maximal depolarization rate of the 
cardiac action potential (Vmax) by virtue of its ability to inhibit sodium ion influx 
via sodium channels. This Vmax depression by bupivacaine is considerably more 
than lidocaine compared to ropivacaine that is intermediate between the two.14 In 
addition, the rate of recovery from a use-dependent block is slower in bupivacaine-
treated papillary muscles. Moreover, high blood levels of bupivacaine will prolong 
conduction time through various parts of the heart indicated by prolongation of PR 
interval and QRS complex. It also exerts dose-dependent negative inotropic action 
on cardiac muscle. 
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DEXMEDETOMIDINE:  
HISTORY: 
Dexmedetomidine is a potent, highly selective and specific alpha-2 
adrenergic receptor agonist. It has both analgesic and sedative properties. The 
prototype of it, clonidine was initially developed in 1960s as a nasal decongestant 
for its vasoconstriction action. In 1966 it was established as a potent 
antihypertensive drug . Dexmedetomidine was approved in the USA in 1999 for 
sedation and analgesia in the intensive care unit. Since then it is used elaboratively 
in various other clinical conditions including anxiolysis, analgesia, as an adjuvant 
in both general anesthesia and central neuraxial blockade. 
PHARMACOLOGY42: Structure: 4-(cs)-alpha, 2, 3-trimethyl benzyl 
imidazole mono hydrochloride.  
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MECHANISM OF ACTION42: 
Alpha-2 agonist acts at pre synaptic and postsynaptic receptors. The human 
alpha-2 receptors are classified into 3 subtypes, 2A, 2B and 2C.Drug binding at 
each receptor results in specific action.4, 5. 2A receptor agonist mediates sedative 
and anti nociceptive actions. Whereas 2B receptor activation causes 
vasoconstriction, resulting in   hypertension at higher doses. 2C subtype modulates 
dopaminergic neurotransmission, hypothermia. 
Dexmedetomidine can induce analgesia by acting at three sites: brain stem, 
spinal cord and in peripheral tissue. Dexmedetomidine is an selective alpha-2 
agonist, with 2A subtype selectivity which makes it effective sedative and 
analgesic agent without undesirable cardiovascular effects from alpha-1 activation. 
In spinal cord alpha-2 receptors situated in the neurons of superficial dorsal horn 
especially lamina 2. Here pain transmission is reduced directly, by decreasing 
release of proprioceptive transmitter, substance P and glutamate from primary 
afferent terminals. 
At cellular level drug binds to transmembrane receptor coupled to G protein 
and decreases adenylate cyclase and cAMP formation. Causes hyperpolarization 
via G-protein mediated potassium channel activation and decreases influx of 
calcium ions. Final result will be decreased action potential at spinal inter neurons 
and decrease in nor epinephrine release at locus coeruleus. 
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Pharmacokinetics 
Following intravenous administration, dexmedetomidine exhibits the 
following pharmacokinetic parameters:   
Distribution half-life (t1/2)                        6 minutes;  
Elimination half-life (t1/2)                        2 hours;  
Steady-state volume of distribution (Vss) 118 liters. 
Clearance                                                    39 L/h. 
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Distribution 
The protein binding is 94%. Protein binding was similar in males and 
females.  The plasma protein binding of dexmedetomidine is decreased in patients 
with liver disease. 
The displacement of dexmedetomidine by other protein binding drugs like 
fentanyl, lignocaine, theofylline, ketorolac, and digoxin has been studied in vitro, 
and is found to be negligible.  
Metabolism 
Dexmedetomidine undergoes complete biotransformation with very little 
unchanged form excreted in urine and feces. Biotransformation includes direct 
Glucuronidation to inactive metabolites and cytochrome P450 mediated 
metabolism. 
N- glucoronidation to inactive metabolites, the glucoronide of 3-hydroxy- and 3-
carboxy metabolite.  N methylation of dexmedetomidine to generate 3-hydroxy N-
methyldexmedetomidine,  and dexmedetomidine-N-methyl O –glucuronide. 
Elimination 
After complete biotransformation 95% of the metabolites are excreted in 
urine and 4% in feces, 
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SYSTEMIC EFFECTS: 
 
 Effects on Cadriovascular system 
The biphasic effect of dexmedetomidine on blood pressure is dependent on 
dose of the drug administered. It has both cental and peripheral action. At low 
doses decreases norepinephrine release at the nueroeffector junction and inhibits 
the neural transmission in symphethatic nerves44 leading to decreased 
catecholamine levels in circulation. .The final effect being slight fall in blood 
pressure and moderate fall in heart rate 45. In patients with pre existing 
hypovolemia or vasoconstriction dexmedetomidine causes significant hypotension. 
Administered At higher doses, dexmedetomidine acts at alpha 2b receptors, 
producing hypertension 
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Respiratory system effects 
Dexmedetomidine does not cause respiratory depression even when 
administered at higher doses. It was also demonstrated that combination of alpha2 
adrenoreceptor agonist opioids does not lead to further ventilator depression47. 
Central Nervous system effects 
Dexmedetomidine action at alpha 2A receptors at locus ceruleous produces 
sedation. The mechanism is different from propofol and benzodiazepines, which 
acts at GABA receptors at cerebral cortex. It also has anxiolytic and analgesic 
properties48. 
Unique nature of sedation produced by dexmeditomidine is co-operative 
form.  Patient will remain calm and   readily arousable to verbal or tactile stimulus. 
This mimics natural sleep and preserves task performing ability and easy 
communication. When not stimulated patients will drift into sleep 49. The drug has 
neuroprotective property by virtue of its action at 11 imidazolione imidozoline 
receptors in the brainstem and hippocampus50 
Analgesia 
 Its action at Spinal cord is the major cause of analgesic action. By inhibiting 
release of substance P from the dorsal horn leads to primary analgesic effect. 
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Renal System Effects 
Stimulation of alpha 2 receptors in the kidneys results in diuresis and 
natriurisis. It reduces efferent sympathetic outflow of the renal nerve and decreases 
the secretion of vasopressin. Dexmedetomidine antagonizes its effect on renal 
tubules. Also increases the release of atrial natriurisis peptide results in 
natriuresis51 
Endocrine system effects 
It Acts on symphethetic outflow and decreases circulating catecholamines 
levels. It attenuates stress response by inhibiting the secretion of 
adrenocorticotropic harmone (ACTH) and cortisol51. It directly inhibits insulin 
release leading to identifiable raise in serum glucose52 
CLINICAL USES OF DEXMEDETOMIDINE:  
1.Used as premedicant to decrease anxiety, and to alleviate intubation response 
when used at dose 0.5- 1mic/kg i.v or i.m.  
2. as an adjuvant to general anesthesia drugs. Decreases over all requirement of 
narcotic and volatiles intra operatively.  
3.Thoracic and cardiac surgeries: decrease in oxygen consumption, reduced 
occurrence of myocardial infarction. Cardioprotective in vascular surgeries  
4. procedural sedation in MRI, endoscopy. Colonoscopy.  
5. to facilitate awake intubation.  
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6. In obese patients posted for bariatric surgeries dexmed infusion decreased need 
of opioids.  
7. In regional anaesthesia as adjuvant to local anaesthetics to prolong duration of 
analgesia.  
8. In ICU to sedate ventilated patients.  
ADVERSE EFFECT: 
It causes dry mouth, bradycardia,  hypotension, hypertension, atrial fibrillation, 
nausea. Mostly these side effects occur during the infusion of loading dose. 
The effects of dexmedetomidine are reversible with antepimazole its use in humans 
not  proven. 
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REVIEW OF LITERATURE: 
El-Hennaway et al (-British Journal of Anaesthesia 2009)53Sixty patients (6 
months to 6 yr) were evenly and randomly assigned into three groups in a double-
blinded manner. After sevoflurane in oxygen anaesthesia ,each patient received a 
single caudal dose of bupivacaine 0.25% (1ml/kg) combined with either 
dexmedetomidine 2µg/kg in normal saline 1ml, clonidine 2µg/kg in normal saline 
1ml or corresponding volume of normal saline. Addition of dexmedetomidine or 
clonidine to caudal bupivacaine significantly promoted analgesia time (16 hrs and 
12 hrs respectively) than the use of bupivacaine alone (5hrs)8.they found no 
significant difference  in incidence of haemodynamic changes or side effects 
Saadaway et-al. (Acta Anaesthesiologica scandinavica. 2009 Feb52) in a 
randomized double blind study involving 60 children aged 1-6 years undergoing 
sub umbilical operation, comparison was done between 1ml/kg of 0.25% 
bupivacaine and same dose of bupivacaine with dexmedetomidine 1µgm/kg. It was 
concluded that addition of   dexmedetomidine to bupivacaine prolongs duration of 
postoperative analgesia (18.5 ± 2.8hrs  versus 6.2±2.8hrs)5. Total consumption of 
rescue analgesic was significantly lower in Group BD compared with Group B (P 
< 0.01). There was no statistically significant difference in hemodynamics between 
both groups  
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Vijay G Anand, et al.( Indian Journal of Anaesthesia 2011)54 
In a randomized, prospective, parallel group, double blinded study involving 60 
children aged 6 months to 6 yrs for lower abdominal surgeries, comparison was 
done between 0.25% ropivacaine 1ml/kg with dexmedetomidine 2µgm/kg and the 
same dose of ropivacaine with 0.5 ml normal saline. It was concluded that addition 
of dexmedetomidine to ropivacaine prolongs duration of postoperative analgesia 
(14.5hrs versus 5.5 hrs)6      
Mausumi Neogi et al-(J Anaesth Clin Pharmacol 2010)55 
Authors studied effect of clonidine with ropivacaine, dexmedetomidine with 
ropivacaine,  and plain ropivacaine in caudal anaesthesia in 75 children undergoing 
elective inguinal hernia repair surgeries. Patients received 1ml/kg of 0.25% 
ropivacaine caudally. Group C patients received 1ml/kg of 0.25% ropivacaine and 
1µgm/kg clonidine. Patients of group D were given 1ml/kg of 0.25% ropivacaine 
and 1µgm/kg dexmedetomidine. The mean duration of analgesia was 6.32±0.46 hrs 
in group R, 13.17±0.68 hrs in group C and 15.26±0.86 hrs in group D. they 
concluded that the addition of alpha 2 agonists clonidine or dexmedetomidine 
prolongs  post operative analgesia. Authors also observed that all the patients were 
hemodynamically stable during and after surgery. 
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K Sudheesh and SS Harsoor et al (IJA 2011)56 
Authors discussed various uses and routes of administration of dexmedetomidine 
in clinical practice of anaesthesia in article they have mentioned that 
dexmedetomidine has been used in children through caudal route successfully at 
the doses 1to 2mcg/kg with local anesthetics bupivacaine and ropivacaine to 
prolong post operative analgesia without undue side effects like hypotension and 
bradycardia. 
Xiang Q, Huang Zhao et al (British journal of anesthesia 2012)57:  
Authors studied use of dexmedetomidine use in caudal anesthesia as an adjuvant  
with bupivacaine in attenuating response to hernia sac traction  in terms of heart 
rate and rise in systolic blood pressure. Study was done in patient’s age less than 3 
years and more than 1 year undergoing unilateral herniotomy. They found that 
there was decreased response (3.33%) in group receiving  1mcg/kg 
dexmedetomidine compared to (43.33%)  patients responding to tractional pain in 
plain bupivacaine 0.25% . they also noticed better duration of analgesia in 
dxmedetomidine group with decreased consumption of  opioid-fentanyl post 
operatively. 
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Merkel et al: ((Peadiatric nursing 1997)23 
Evaluated reliability and validity of the FLACC pain assessment tool  in 89 
children aged 2 months and 7 years  who underwent variety of surgeries. They 
concluded that FLACC scoring provides simple framework to quantify pain in 
children who may not able to verbalize the presence or severity of pain  
Sheta et al (international journal of pediatrics 2009):  
Authors compared different doses of oral midazolam for premedication in 
paediatric age group. Doses compared were 0.5mg, 0.75mg/kg, and 1mg/kg 
midazolam. Observed for effectiveness in anxiolysis during parental separation and 
venepuncture. They found 0.5mg/kg oral midazolam as effective and acceptable 
dose as premedication and does not alter recovery time after general anaesthesia.  
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METHODOLOGY 
STUDY DESIGN:  
This was a Prospective Double blinded Randomized Comparative  clinical trial  
conducted in Government Stanley Hospital, paediatric surgery department Chennai 
from April 2012 to August  2012.  Children who were admitted to the paediatric 
surgery department for elective lower abdominal   and perineal surgeries  
satisfying selection criteria  were included in the study. 
RANDOMIZATION: 
The randomization was done by assistant, using simple lot system. We wrote equal 
number of letter A and B (50 envelopes contained letter A and 50 envelopes letter 
B) in a closed envolopes. Patients were asked to pick up one envelope randomly. 
Patients were assigned  in a group whichever letter the envelope contained. The 
drug preparation was made by the assistant based on selected patients group. 
Caudal block was performed by the investigator, Intra operative monitoring and 
post operative observations were made by the same 
BLINDING: The patient’s parents/guardians were not aware, to which group the 
child belongs to. and the investigator was also blinded as the  randomization and 
drug preparation was done by assistant  who was not involved in the study. 
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DRUG PREPARATION:   
Group A: 1ml/kg of 0.25% bupivacaine was prepared from 0.5% bupivacaine by 
adding equal volume of distilled water.  
Group B: dexmedetomidine available as 100mcg/ml was diluted with 9ml of 
distilled water, into 10mcg/ml. Based on weight 2mcg/kg added to 0.5% 
bupivacaine and solution was made up to 1ml/kg of 0.25% concentration by adding 
distilled water. 
Children who were included in the study, received   1ml/kg   of study solution 
which was not labeled. The study blinding was broken, after the completion of all 
100 cases and data sent for statistical analysis,   Using observational data two 
groups were compared prospectively and statistic analysis made to derive 
conclusions.     
SAMPLE SIZE CALCULATION: 
Before the start of the study ,Pilot study was done with a sample size of 10 patients 
in each group, to decide on sample size. The mean and standard deviation of 
duration of post operative analgesia was calculated from pilot study.  The sample 
size was calculated based on the formula given in NTI Bulletin 2006. (Sample size 
determination in health studies, V. K. Chadha,, National Institute Bulletin 2006, 
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42/3 & 4m 55-62.).From the pilot study  got the value of mean and standard 
deviation.   
Duration of post operative analgesia of Group-A (3.59 ± 0.59) and Group-B (15.14 
± 2.02). 
n = ([Z1-α/2 + Z 1-β] 2  ( 2σ2 ) ) /(d)2    = (8.98 * 1.44) /0.13 = 99.5 
Duration of Analgesia in a pilot study with 10 children in each group: 
Z1 -α/2   = 1.96 (5%) 
Z1-β    = 1.037 (85 % Power) 
[Z1-α/2 + Z 1-β] 2  = (1.96 +1.037 )2   = 8.98 
S= (s1 +s2) / 2 
S =(0.69+0.98)/2 =0.72 
S2 = (0.72)2=0.52 
2 σ2=0.52*2 =1.44 
d = (Mean1 –Mean2)= (9.12-9.48)= 0.36 
d2= 0.13 
From the above calculation sample size was decided as 100  
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CRITERIA FOR PATIENT SELECTION: 
After complete physical examination and basal investigations children were 
selected based on criteria:  
2-7 years  age  
either male or female sex,  
belonging to ASA I or II physical status,  
Children undergoing elective lower abdominal or urologic surgeries like 
Herniotomy, Orchidopexy, appendicectomy, Procesus vaginalis sac ligation, 
Circumcision and Urethroplasty were included in the study. 
EXCLUSION CRITERIA: 
The children with the following problems were excluded from the study: 
¾ Local infection in the Caudal region  
¾ Preterm neonate 
¾ Pre-existing Neuromuscular disease 
¾ Congenital anomaly of the lower back 
¾ Mental retardation, Delayed development 
¾ Bleeding disorders or coagulopathy  
¾ Parent refusal for the procedure. 
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METHODOLOGY: 
After  Obtaining clearance from the Institutional Ethics Committee of the 
Stanley Medical College, Chennai-1. The study was explained in detail to parents 
before including child in trial  and written Informed Consent obtained from them. 
The children were fasted for 6 hours for solids and 2 hours for clear 
liquids37. All children were premedicated with oral Midazolam syrup (2mg/ml)  
0.5mg/kg45 minutes before surgery. EMLA patch was applied over dorsum of 
hand at the same time. They were brought into the operation theatre. The baseline 
parameters like heart rate, oxygen saturation; blood pressure measured.Precardial 
stethoscope was attached. intravenous access was secured with 22G  intravenous 
canula . Intravenous fluid was started with  Ringers lactate. 
Inj. glycopyrolate 0.01mg/kg and inj fentanyl 1mic/kg   i.v. administered.  
Oxygenated with 100% oxygen, Induced with inj thiopentone 5mg/kg. patients 
were intubated under direct laryngoscopy with appropriate size  oral uncuffed 
endotracheal tube, 45 seconds after injecting 1mg/kg of inj suxamethonium.  the 
tube position confirmed by auscultation and secured with elastoplaster. Anesthesia  
Maintained with 50% N20 and o2 50% mixture  and sevoflurane 1%. Inj 
atracurium 0.1mg/kg given after recovery from suxamethonium and repeated when 
required. 
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CAUDAL BLOCK: 
The children were  placed in left lateral position after general anesthesia. 
Under strict aseptic precautions, patient’s lower back was painted and draped. 
After palpating the landmarks and sacral hiatus,  new 22G hypodermic needle was 
introduced in Caudal epidural space.  To detect and avoid an inadvertent 
intravascular or subarachnoid injection, drug  was injected after aspiration was 
negative for CSF or blood. Assistant who was not involved in the study, who 
prepared drug solution as above, handed over a unlabeled syringe for caudal. 
1ml/kg of study solution was administered  slowly,  while monitoring vital signs 
and ECG. Then the patients were placed in Supine position, tube position 
reconfirmed. .  The surgeons were requested to put the incision, 10 min after 
Caudal block, as the average onset time of caudal is around 10 min.  
Heart rate, Blood pressure and Oxygen saturation was monitored 
continuously; values were recorded, after intubation, during caudal procedure and 
at the time of incision, then every 10 minutes interval till the end of surgery. If the 
patient responded to the surgical incision with a greater than 15% increase in 
Systolic Blood pressure or 15% rise in Heart rate ,it was planned to give  Inj. 
Fentanyl 1 microgram/kg i.v.    
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Significant bradycardia  requiring intervention was defined as fall in heart 
rate more than 20% from base line38 and was planned to treat with injection 
Atropine 0.02 mg/kg. Significant hypotension requiring treatment was defined as 
more than 20% fall in Systolic blood pressure from baseline or systolic blood 
pressure less than 90 mmHg, and was planned to treat with intravenous fluid bolus 
10ml/kg 0.9% normal saline. 
At the end of the surgery, residual neuromuscular blockade was reversed 
with Inj. glycopyrolate 0.02mg/kg i.v. and with Inj. Neostigmine 0.05mg/kg i.v.   
The child was extubated when patient was hemodynamically stable, opens eyes to 
verbal commands and moves upper limbs purposefully. When the child was able to 
maintain room air saturation > 98%   shifted to the recovery room for Observation. 
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POST-OPERATIVE PERIOD: 
Post-operatively, patient was monitored closely in recovery room for 2 hours 
and later in post operative ward for 24 hours . Pulse rate, Systolic Blood Pressure 
and oxygen saturation recorded every 15min for first 2hrs and every one hour once 
for next 4 hours and then 6th hourly. Complications such as hypotension, 
bradycardia, postoperative nausea and vomiting (PONV),   shivering  were  noted. 
Apart from vitals, quality of Analgesia was assessed by using FLACC 
Objective Pain Scale43 every 2nd hourly for first 12 hours, then 6th hourly. 
Categories 
Scoring 
0 1 2 
Face 
Smile or no particular 
expression 
Occasional grimace from, 
withdrawn, disinterested 
Frequent to constant 
frown, clenched jaw, 
quivering chin 
Legs 
Normal position or 
relaxed 
Uneasy, restless, tense Kicking, or legs drawn up
Activity 
Lying quietly, Normal 
Position, Moves easily 
Squirming, shifting back and forth, 
tense 
Arched, rigid, jerking 
Cry No cry (awake or asleep)
Moans or whimpers, Occasional 
complaint 
Crying steadily, screams, 
sobs, frequent complaints
Consol ability Content, relaxed 
Re assured by occasional touching, 
hugging, or talking to, distractible
Difficult to console 
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Duration of analgesia was defined as “the time interval from the 
administration of caudal block and the  requirement of first rescue  analgesia for 
the patient”. This time was noted. Inj. Fentanyl 1mcg/kg was given as rescue 
analgesia. Subsequent pain was treated with paracetamol rectal suppository 
15mg/kg70  when the FLACC pain score equals or exceeds 4.All analgesic 
requirements were noted in terms of   number of times analgesic required in 24 
hours. PONV treated as needed with ondansetron 0.06mg/kg. Bradycardia  was 
planned to treat with injection Atropine 0.02mg/kg, Hypotension was planned to 
treat with 10ml/kg normal saline.  
PARAMETERS OBSERVED:  
1. Duration of  analgesia. 
2. Analgesia requirement in 24 hours. 
3. FLACC score at regular intervals. 
4. Hemodynamic changes in terms of heart rate and blood pressure. 
5. Other side effects like nausea, vomiting and shivering. 
STATISTICAL ANALYSIS 
A sample size of 100 was decided based on pilot study results and 
Randomized into two groups consisting 50 children in group A and 50 in group B. 
Data was expressed as mean+/- standard deviation. Quantitative variables 
like age sex and weight were  analysed   using  student`s t-test. For continuous 
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variables like heart rate, blood pressure, duration of analgesia in hours, FLACC 
score, Chi-square test applied . When using the above statistical tests to compare 
the mean among the two groups, a p-value of less than 0.05 was taken as 
significant. All values were rounded off to a maximum of two decimals. 
The children in each group were comparable in distribution in terms of age, 
weight, sex and basal parameters. 
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Table-5 
DURATION OF SURGERY: 
There was no difference in the duration of surgery between the two 
groups with a maximum duration of 50 min. The average duration of 
surgery was around 32 min in both groups.  
 
 
 
TYPE OF SURGERY:   
Type of surgery between two groups were similar .The level of blockade 
required was similar in both groups.  
Surgery Group A Group B Total 
N % N % N % 
PVSL 2 4 3 6 5 5 
URETHROPLASTY 6 12 6 12 12 12 
HERNIOTOMY 16 32 13 26 29 29 
PVSL+CIRCUMCISION 7 14 7 14 14 14 
CIRCUMCISION 3 6 2 4 5 5 
ORCHIDOPEXY 13 26 14 28 27 27 
Others 3 6 5 10 8 8 
TOTAL 50 100 50 100 100 100 
Chi-square 1.78 DF=6 significant value =0.94 (Not Significant)   
         
  Group-A Group-B 
Mean 31.9 32.4 
Sd 11.95 13.02 
t-Value 0.2 
Df 98 
p-value 0.84 (Not Significant ) 
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There was no desaturation either in the intraoperative or 
postoperative periods in both the groups.  
                                                                                                                                           
HEMODYNAMIC CHANGES: 
We observed for change in heart rate throughout surgery and 24 hours 
post operatively.  At the intervals of 10 minutes during first hour then 15 
minutes once for two hours then half hourly and second hourly for 12 
hours.. There was decrease in heart rate after caudal block in both the 
groups but magnitude being more in group B and was significant for first 
50 minutes. The decrease in heart rate was less than 20% and the rate was 
maintained average around 115 none of them requiring intervention. The 
mean value was between 112 and 124. 
Table : 7 
Heart Rate intra operative 
Heart Rate   Group –A Group-B t-value p-Value 
Mean ± Sd Mean ± Sd Df=98 
basal heart 
rate 
139.22± 17.70 144.12± 11.31 1.65 0.102 
Intubation 134.48± 17.07 124.00± 10.44 3.7 0.0001* 
Caudal 133.66± 16.56 118.50± 10.38 5.49 0.0001* 
10 min   129.66± 14.78 119.12± 08.67 2.42 0.02* 
20 min 128.76± 16.09 115.98± 09.70 4.81 0.0001* 
30 min 126.36± 15.66 113.56± 17.30 3.88 0.0001* 
40 min 126.34± 15.30 114.66± 09.67 0.45 0.65 
50 min 124.70± 15.48 112.36± 16.06 3.91 0.0001* 
* - Significant   
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POST OPERATIVE HEART RATE: there was no significant change 
in heart rate between two groups post operatively. There was a mild rise 
in heart rate at 120 min in group A, which could be wearing up of caudal 
and patients starting to get pain. 
Table-8 
Heart Rate post operative  
Heart Rate   Group –A Group-B t-value p-Value 
Mean ± Sd Mean ± Sd Df=98 
15   Minutes  120.00 ± 14.92 117.26 ± 05.83 1.21 0.23 
30   Minutes 121.00 ± 12.80 118.36 ± 04.56 1.71 0.09 
45   Minutes 120.00 ± 16.02 115.50 ± 07.43 1.8 0.08 
60   Minutes 118.44 ± 14.02 114.26 ± 07.94 1.75 0.08 
75   Minutes 117.88 ± 12.36 114.26 ± 08.08 1.73 0.09 
90   Minutes  115.76 ± 20.77 115.44 ± 11.04 0.1 0.92 
120  Minutes  117.06 ± 13.04 112.50 ± 17.24 1.49 0.14 
150  Minutes 116.22 ± 12.96 115.80 ± 8.99 0.19 0.85 
180  Minutes  115.80 ± 11.95 115.72 ± 8.92 0.04 0.97 
4    Hours  115.18 ± 13.50 115.00 ± 9.59 0.08 0.94 
6    Hours 115.50 ± 11.67 115.54 ± 9.01 0.02 0.99 
8    Hours 115.76 ± 20.77 115.38 ± 11.04 0.1 0.92 
10  Hours 115.30 ± 12.02 115.52 ± 08.99 0.11 0.91 
12  Hours 115.06 ± 12.05 115.44 ± 11.04 0.16 0.87 
24  Hours  115.73 ± 20.78 115.40 ± 11.06 0.07 0.92 
* - Significant  
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BLOOD PRESSURE CHANGE:  
Pre operative basal systolic blood pressure was comparable between two 
groups.  The mean systolic BP in group A was between 96+/-14.8 to 
108+/- 8.25 .in group B  mean was 94+/- 6 to 100+/- 8 intra 
operatively.The fall in BP was significantly more in group B compared to 
group A during 40 and 50 minutes after caudal block ,  this could be due 
to the absorption of dexmedetomidine and peak action on cardiovascular 
system. The drop in systolic BP was not > 20% which may need 
intervention 
Systolic Blood Pressure intra operative 
Systolic blood 
pressure 
Group –A Group-B t-value p-Value 
Mean ± Sd Mean ± Sd Df=98 
Pre OP basal 108.28 ±8.25 110.14 ± 8.90 1.08 0.28 
Intubation 100.54 ± 7.96 100.64 ± 8.39 0.06 0.95 
Caudal 99.10 ± 8.00 98.62 ± 8.29 0.3 0.77 
10 minute    98.20 ± 8.32 96.56 ±7.58 1.03 0.31 
20 minute 96.48 ± 14.80 93.12 ± 15.53 1.11 0.27 
30 minute 97.70 ± 8.04 95.00 ± 7.55 1.73 0.25 
40 minute 98.34 ± 8.12 94.48 ± 7.35 2.49 0.01* 
 60 Minute 98.84 ± 8.92 94.42 ± 7.08 2.74 0.01* 
* - Significant  
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POST OPERATIVE SYSTOLIC BLOOD PRESSURE:  
 There was no significant difference between group A and group B in 
post operative systolic blood pressure. 
Table -9 
 
* - Significant  
  Group –A Group-B t-value p-Value 
Mean ± Sd Mean ± Sd Df=98 
15   Minutes   99.30 ± 8.44 96.22± 9.15 1.75 0.08 
30   Minutes 99.62 ± 9.72 96.82± 8.54 1.53 0.13 
45   Minutes 99.02 ± 8.68 95.98± 6.94 1.93 0.06 
60   Minutes 99.05 ± 8.68 96.22± 9.15 1.51 0.14 
75   Minutes 99.03 ± 8.67 96.96± 7.15 1.3 0.2 
90   Minutes  98.64 ± 8.55 96.60± 7.05 1.71 0.09 
120  Minutes  98.48 ± 8.55 96.48± 6.59 1.2 0.23 
150  Minutes 98.90 ± 7.75 96.56± 6.65 0.8 0.42 
180  Minutes  98.74 ± 9.21 96.96± 7.15 1.08 0.28 
4    Hours  98.62 ± 9.10 96.40± 7.09 1.36 0.18 
6    Hours 98.00 ± 8.33 96.26± 6.84 1.14 0.25 
8    Hours 98.44 ± 8.96 96.60± 7.05 1.19 0.26 
10  Hours 98.12 ± 8.29 96.44± 6.06 1.16 0.25 
12  Hours 98.02 ± 7.93 96.20± 5.60 1.33 0.19 
24  Hours  98.00 ± 7.72 96.60± 6.42 0.99 0.33 
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Systolic Blood Pressure post operative 
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DIASTOLIC PRESSURE:  There was slight decrease in diastolic blood 
pressure from base line in both the groups .there was no significant difference 
between group A and group B,  both intra operative and post operative period. 
Diastolic Blood Pressure intra operative 
Table :10 
Time    Group –A Group-B t-value p-Value 
Mean ± Sd Mean ± Sd Df=98 
 Basal  56.46 ± 5.64 57.24 ± 6.69 0.63 0.53 
 Intubation 54.82 ± 5.10 55.00 ± 6.04 0.16 0.87 
 Caudal 54.42 ± 5.36 53.98 ± 5.61 0.4 0.69 
10 minute  54.12 ± 5.09 53.76 ± 5.35 0.35 0.73 
20 minute 53.74 ± 5.07 53.30 ± 5.26 0.43 0.67 
30 minute 53.80 ± 5.65 53.36 ± 5.70 0.39 0.7 
40 minute 53.52 ± 5.12 53.18 ± 5.03 0.34 0.74 
50 minute 53.72 ± 5.25 51.86 ± 7.63 0.7 0.49 
* - Significant   
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 FLACC SCORING  post operatively:  
At 2 hours after surgery FLACC score was less than 3 for all the patients, 
none of them required rescue analgesia.   
Table-12 
FLACC  2 hours 
FLACC Score Group-A Group-B 
N % N % 
0 33 66 39 78 
1 8 16 8 16 
2 5 10 2 4 
3 4 8 1 2 
Total  50 100 50 100 
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 FLACC score at 4 hours: 
At 4 hours after caudal drug administration. 24 (48%) patients out of 50 
in group A had FLACC score more than or equal to 4 .  They   received 
rescue analgesia inj fentanyl 1mcg/kg iv. 
Where as in group B none of the children complained of pain and the 
FLACC score was less than 4 at the end of 4 hours. 4 hours 
Table-12 
FLACC score 4 hours Group-A Group-B 
N % N % 
0 6 12 15 30 
1 6 12 20 40 
2 9 18 14 28 
3 5 10 1 2 
4 10 20 0 0 
5 6 12 0 0 
6 6 12 0 0 
7 1 2 0 0 
8 1 2 0 0 
Total  50 100 50 100 
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FLACC score at 6 hours. 
FLACC at the end of six hours only 7 (14%) children out of 50, required 
rescue analgesia and the pain scores were less than 5. Whereas in group A  
26(52%)  out of 50   children  had FLACC score more than 4. At the end 
of 6 hours all patients  in group A had received rescue analgesia. 
6 hours 
Table :13 
 
  
  
 
 
 
FLACCscore 6 hours Group-A Group-B 
N % N % 
0 0 0 2 4 
1 0 0 14 28 
2 6 12 22 44 
3 18 36 5 10 
4 8 16 5 10 
5 11 22 2 4 
6 3 6 0 0 
7 3 6 0 0 
8 1 2 0 0 
Total 50 100 50 100 
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FLACC at 8 hours:  
In group B only 4 (8%) children out of 43 had FLACC score of 4 and 
received rescue analgesia, remaining 46 children were calm and did not 
have pain. They were calm and comfortable. In group A patients who had 
received rescue analgesia at early (<4 hours), started complaining of pain 
and required extra analgesic supplementation, paracetmol 15mg/kg. 
Table-14 
 
 
 
FLACC score 8 
hours 
Group-A Group-B 
N % N % 
1 0 0 3 6 
2 9 18 29 58 
3 25 50 14 28 
4 3 6 4 8 
5 4 8 0 0 
6 3 6 0 0 
7 4 8 0 0 
8 2 4 0 0 
Total  50 100 50 100 
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FLACC at 12 hours:   
In group B, 6 out of 31 patients required rescue analgesia. In group A  40 
patients required a supplementation of analgesia.  
Table-15 
FLACC score 
12 hours 
Group-A Group-B 
N % N % 
1 0 0 1 2 
2 2 4 11 22 
3 8 16 31 62 
4 11 22 1 2 
5 13 26 2 4 
6 9 18 1 2 
7 6 12 1 2 
8 1 2 1 2 
Total  50 100 50 100 
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FLACC at 16 hours:  
At 16 hours following caudal:  27 patients belonging to group B needed 
rescue analgesia.   
Table-16 
FLACC score  
16 hours 
Group-A Group-B 
N % N % 
1 0 0 1 02 
2 5 10 4 08 
3 8 16 18 36 
4 16 32 11 22 
5 11 22 6 12 
6 7 14 6 12 
7 3 06 3 6 
8 0 0 1 2 
Total  50 100 50 100 
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FLACC score at 18 hours.  By the end of 18 hours all the patients in 
group B had received rescue analgesia the pain score in group B was 
lower compared to group A. 
Table-17 
 
FLACC score 18 
hours 
Group-A Group-B 
N % N % 
2 0 0 4 8 
3 5 10 11 22 
4 12 24 15 30 
,5 14 28 10 20 
6 11 22 5 10 
7 6 12 3 6 
 8 2 4 2 4 
Total  50 100 50 100 
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POST OPERATIVE ANALGESIC REQUIREMENT: 
The number of times patients received analgesia was more in group A compare to 
group B. 68% patients in group B required only once supplementation of paracetamol. 
48%  patients in group A received paracetmol 15mg/kg  analgesia three times in 24 
hour compare to only 3(6%) patients in group B.7(14%) patients in group B did not 
required paracetamol supplementation  in 24 hours versus all patients in group A 
required analgesic supplementation . Number of times the additional analgesia 
required was more in group A and hence the total analgesia consumed is more in 
group A. 
Post operative analgesia requirement 
No of times Analgesia 
given 
Group-A Group-B 
N % N % 
0 0 0 7 14 
1 6 12 34 68 
2 20 40 6 12 
3 24 48 3 6 
Total  50 100 50 100 
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DISCUSSION:  
        Eventhough neonates and children are able to perceive pain as adults do, 
they have been undertreated or often neglected. Misconceptions leading to 
inadequate pain treatment in children are:  myth that children do not feel pain or 
remember such events, difficulty in assessing pain, deficiency in knowledge in 
physician about drugs strategy and newer modes of pain relief in children, fear of 
overdosage  of pain medications  and its  side effects. Patient factors like  
improper expression of pain by paediatric patients due to lack of such experience, 
difference in cognitive and emotional development towards pain in children.1 
              Inadequate pain relief in paediatric age group shown to have long term  
adverse effects like disrupted sleeping and food habits, behavioural changes, 
harmful neuronal and endocrine responses. They are prone to perceive more pain 
on subsequent pain exposure. Hence pain management becomes most important 
component of peadiatric anaesthesia practice. 4,5,6(anand KJ et al, peter JW et al)    
        There are different modes of pain management58 in post operative 
period for children undergoing abdominal surgeries. Oral acetaminophen , 
morphine which cannot be administered in immediate post operative period. 
Rectal administration of  drugs like diclofenac , acetaminophen suppositories  
have variable bioavailability and inadequate efficacy in alleviating pain .58   
Intramuscular route‐ painful on injection, patient compliance is poor and hence 
strongly discouraged 
 
          Intravenous non ‐opioids like paracetamol, ketorolac and  opioids  like 
morphine, pethidine, fentanyl  are widely used intra operatively. Their use in post 
operative period is limited due to shorter duration of action needing frequent  
dosing intervals .  Continuous  infusion of opioids using  PCA provide pain relief at 
acceptable doses and improves sleep. Opioids have increased risk of  nausea , 
sedation58  other drawbacks is cost effectiveness. It is difficult tp educate the child 
regarding use of PCA58. Now the nurse controlled analgesia and parent controlled 
analgesia are prevalent.   Wound infiltration and topical  anaesthetic application 
have limited use due to short duration of action and does not relieve visceral 
pain.   
       Diclofenac is an analgesic an weekly antipyretic NSAID available for oral. 
Rectal. Intramuscular and recently intravenous administration. Its analgesic effct 
is useful in treating acute pain in paediatrics has been proved. Oral diclofenac 
0.5mg/kg is comparable to analgesic efficacy of 15mg/kg paracetamol (Standing 
JF et al 2009 )60  . It has usual side effects of NSAIDS like nausea vomiting, 
prolonged bleeding time. 
 Ketorolac is a moderately anti inflammatory drug and potent analgesic 
when administered IM or IV. It exhibits  analgesic effect by inhibiting cox enzyme 
and prostaglandin synthesis. It has no cardiovascular or ventilator depression 
action.  Ketorolac can prolong bleeding time on single iv injection in spinal 
anaesthesia.(Thwaites et al 1996)36. It Can cause severe bronchospasm in patients 
with asthma and aspirin sensitivity.( Haddow et al)36. Due to side effects like GI 
irritation, bleed, nausea and peripheral oedema NSAIDs are not regularly used in 
children.  
Acetaminophen   is effective in  mild to moderate  pain management.  . It 
has got excellent safety profile and has  lesser side effects at therapeutic doses(15-
20mg/kg). It acts by inhibiting central prostaglandin synthesis. The dose required 
to produce analgesia is more compared to requirement of drug to  decrease 
temperature58. Its metabolite  N-Acetyl –P –benzoquinone-imine s hepatotoxic. But 
growing liver produces higher level of glutathione peroxidase and is protective 
against hepatotoxicity in children. At higher doses  P-Aminophenol accumulation 
causes papillary necrosis and and analgesic induced nephropathy.Acetaminophen 
can be administered  oral rectal, intramuscular or intravenous routes. Maximum 
allowable dose is 90mg36,58,59. 
 
    Regional techniques are central neuraxial blocks and  peripheral  blocks.  Ilio 
inguinal, iliohypogastric block for herniotomy, orchidopexy. Penile block for 
circumcision. Central neuraxial blocks like spinal, Single shot caudal epidural, 
continuous epidural infusion, paravertebral blocks for abdominal, perineal and 
lower limb orthopaedic surgeries can be used for abdominal and lower limb 
surgeries. Raafat S. Hannallah,M.D., et al (Anesthesiology 1987)35  evaluated 44 
children aged 1.5-12 years scheduled for ambulatory orchidopexy under caudal 
analgesia and ilioinguinal /iliohypogastric nerve blocks for postoperative analgesia. 
Found that caudal block is superior to ilioinguinal block  
          Among all above mentioned modalities of post operative pain relief caudal 
block is most commonly used since decades. It is   well tolerated and most 
reliable method. Caudal block  provides  effective and extended post operative 
pain relief with lesser side effects. It has advantages like : local anesthetic with 
additives can be administered as a single injection to prolong post operative 
analgesia. Requires lesser number of pricks compare to regional blocks.   
Caudal analgesia has shown better  outcomes like early extubation, reduced 
length of hospital stay, early return of intestinal function61 .Decreased 
requirement of  anesthetic drugs  and volatile intra operatively8.  
            Bupivacaine is a long-acting amide local anaesthetic that has provided reliable 
anaesthesia and analgesia with differential motor-sensory blockade for more than 
40 years.9,10 ( steel GC et al, watt MJ et al). The average duration of action of 
bupivacaine is about 4 -6 hours. It acts by inhibiting sodium channels in the nerve 
membrane.  Available as 0.25%,0.5% and 0.75%.  The  motor and the sensory 
blockade of local anesthetics depends on its minimum concentration(Cm) .Cm of 
motor fiber is twice that of sensory fibers.. 0.25% bupivacaine produces  adequate 
motor and sensory blockade in  lower abdominal surgeries. The bupivacaine is 
available as a racemic micture of s(-) and s(+) enantiomer, while ropivacaine is the 
first drug to be available as a pure S-(-) enantiomer. , ropivacaine has an 
intermediate degree of lipid solubility compared to bupivacaine.  Ropivacaine 
Clearance is higher than bupivacaine and elimination half-time shorter38 and hence 
shorter acting compared to bupivacaineThe volume of 1ml/kg was selected based 
on ARMITAGE formula. 
 
. 
 Local anaesthetics are commonly used either alone or with additives. 
Commonly used caudal additives are epinephrine Ketamine,  midazolam,  
tramadol, alpha 2 agonists like clonidine, dexmedetomidine and  opioids like 
morphine, hydromorphine, fentanyl,. ( BJA 2003, miller et al)   . Adrenaline 
5mcg/ml at 1:20000 concentration has been used with lignocaine but its efficiency 
is debatable with  low dose bupivacaine.61  Morphine acts on both spinal and 
supraspinal mu receptors.  Morphine improves both quality and duration of 
analgesia at 0.03,0.06 and 0.1 mg/kg dose61.  Recently extended release epidural 
morphine (EREM) is available. Main side effect of morphine is   late onset 
respiratory depression.   Fentanyl 1mcg/kg is used as a adjuvant to local 
anaesthetics. Few studies showed no added analgesia when fentanyl was added 
with 0.25% bupivacaine61. Buprenorphine, diamorphine at 4mcg/kg dose have been 
tried. Side effects with opioids are nausea, vomiting,  delayed onset respiratory 
depression35 and urinary retention   (Gustafsson et el).  
 Clonidine has been  used for sedation, premedication and analgesia.58,61. 
Studies show increase in duration of post operative analgesia on adding clonidine 
to local anesthetic.(Aruna parameswari et al) ( Klimscha et al )61 . Dose dependent 
hypotension, bradycardia are  less pronounced in children 61. Few studies showed 
apnea, bradycardia and spo2< 80% when used in neonates ( Breschan  C et al).  
       Dexmedetomidine. is the most recent alpha‐2 agonist agent  approved by 
FDA IN 1999 for use in humans for analgesia and sedation. Dexmedetomidine 
differs from clonidine as it posses selective alpha‐2 adrenoceptor agonism.  Action 
at  2A receptor makes it  a much more effective sedative and analgesic agent than 
clonidine (El‐Hennawy et al., 2009) . Addition of  dexmedetomidine resulted in 
prolonged analgesia suggesting a synergistic effct with local anesthetics in 
pediatric surgery (kanazi et al., 2006 acta anesthesia ). Its analgesic effect is due 
to its action at post synaptic alpha 2A receptor situated at substantia gelatinosa of 
spinal cord leading to suppressed release of substance P and hyperpolarization of 
nerve membrane. In addition it has got a active sedation property, with no 
respiratory depression. Hence we decided to evaluate its effect in prolonging post 
operative analgesia when added to bupivacaine in paediatric caudal anesthesia. 
  
In our study we compared plain  bupivacaine and effect of combination of 
caudal bupivacaine and dexmedetomidine  in paediatric age group 2 to 7 years 
undergoing elective lower abdominal and perineal surgeries .In our study  group A 
received 0.25% of bupivacaine 1ml/kg and Group B received 1ml/kg of 0.25% 
bupivacaine and 2mcg/kg dexmedetomidine . We  observed that the duration of 
post operative analgesia in group A was 4.22+/- 1.52 hours, where as in group B 
duration of analgesia was 13.54+/-4.12 hours. The difference was statistically 
significant with P value 0.001, this shows prolonged pain relief on adding 
dexmedetomidine  2mic/kg caudally with bupivacaine 0.25%. This findimg is 
supported by study done by Saadway et al,  in children aged 1 to 6 years. They  
concluded that addition of  dexmedetomidine 1mcg/kg prolongs duration of 
postoperative analgesia    (18.5 ± 2.8hrs  versus 6.2±2.8hrs)52.     Hennaway et al 
who  studied benefit of adding 2mic/kg dexmedetomidine to 2.5mg bupivacaine in 
patients less than six years age and compared with same dose of local anesthetic 
and clonidine. They noticed post operative analgesia for dexmed as 14-18 hours53, 
whereas duration of analgesia  for plain bupivacainem  was 4-6 hours.  
In a Indian study done by Vijay G anand et al, administration of 2mic/kg of 
dexmedetomidine to ropivacaine was also  found to have      enhanced post 
operative  analgesia duration for about 14.5 hours54. For plain ropivacaine 
analgesia duration was only 5.5 hours. 
 
     To assess the quality  and duration of analgesia, Post operative  pain assessment  
was done using FLACC scoring system in our study. .Merkel et al evaluated 
FLACC scoring for assessing pain in children and found that it is reliable and valid 
in quantifying pain in non verbal children23. Group A  achieved significantly 
higher FLACC scores compared to group B. which was significant, Other studies 
like mousumi neogi et al, Hennaway et al, Kannan et al  have also used same 
scoring system to assess post operative pain and have found it reliable in assessing  
pain53,54,55.  
       Visual analog pain (VAS) score is self reporting score it is applicable to older 
children who can grade pain from no pain to severe pain. OUCHER scale has 
photographs of child with increasing degrees of pain, it cannot be used for younger 
children. Behavioral pain score like CRIES which takes account of crying, oxygen 
saturation, increase in heart rate and blood pressure, sleeplessness. it is designed to 
assess pain in term neonates. CHEOPS is applicable to 1-7 year children considers 
cry, facial expression, verbalization, body posture  the score is 4-13.COMFORT 
score system can be applied to all ages but has wide range of score from 0 to 40. 
Among all mentioned scoring system we chose FLACC scoring because it is easy 
to measure scores, can be done both in awake and asleep child, it has grading of 
pain as mild moderate and severe pain, covers non verbal child,   as its only 
observational score not distressing to child during post operative period.  
     There was a significant difference in the FLACC score  between group A and group. Group 
A achieved higher FLACC score which was significant. We checked for  FLACC score second 
hourly  for first 18 hours after caudal block . FLACC score observed at 2hours after caudal in 
both groups was less than 4 and none of them required rescue analgesia.  
 At the end of 4 hours 24/50 children in group A had scores >4 and hence received rescue 
analgesia inj fentanyl 1mcg/kg i.v. In group B none of the children had pain till 4 hours after 
caudal block.   
       At the end of 6 hours 28/50 children  in group A had score more than 4 and received 
fentanyl iv. This could be due to wear up of caudal effect of bupivacaine resulting in higher pain 
scores. Whereas in group B only 7 patients required, rescue analgesia at the end of 6 hours.  
     At 8th hour only 4 cases in group B needed rescue analgesia out of 43. Remaining39 patients 
were free of pain.   
    At 12th hour 6 out of 39 had pain and 33 children had lower PLACC score.  
     At the end of 14th hour 27 patients had received rescue analgesia indicating that the 
dexmedetomidine group had maximum of 14 hours analgesia compared to 6 hours of analgesia 
with plain bupivacaine. 
        Total number of times analgesia required in 24 hours was estimated by noting how many 
times each child was administered paracetamol 15mg/kg. In group A 48% children required 3 
times analgesic supplementation  compared to only  6% in group B. Whereas 82% of children in 
group B required  analgesia for only once  in first 24 hours after surgery. And hence 
dexmedetomidine addition to caudal bupivacaine significantly reduces post operative analgesic 
consumption and better pain relief in children. This is supported by Hennaway et al, Kannan et al 
and mousumi neogi et al and others53,55,57. 
 
       During observations in our study we found that the basal hemodynamic parameters like heart 
rate , systolic and diastolic BP were comparable in both groups There was fall in mean heart rate 
in both the groups after caudal block. The fall in heart rate was more in group B than group A 
and it was statistically significant. The reduced heart rate was not > 20% from basal heart rate 
and hence none of the children required treatment for decreased rate. The fall could be due to 
reduced circulating catecholamines in group receiving dexmedetomidine in addition to 
sympathetic blockade by bupivacaine .The mean heart rate in group A during surgery was 
between 124 – 139 group B 112. Post operative heart rate was  115-121 in group A, where as it 
was constantly around 115 in group  B without much fluctuations . There was a mild rise in 
mean heart rate at 120-150 minutes post operatively in group A, which corresponds to 3-4 hours 
after caudal block, which could be due to wearing up of caudal effect of bupivacaine and patients 
starting to get pain. 
     The mean systolic blood pressure in group A was around 98 intra-operatively and between 98 
and 108 post operatively. Whereas in group B mean systolic blood pressure was around 93 intra 
operative and 96 in post-operative period . During 40th and 50th minute after caudal block there 
was significant decrease in systolic blood pressure in group B but the fall was not > 20% from 
the basal so we did not intervene any of the patients. This fall was may be due to the  systemic 
absorption of dexmedetomidine and  its peak action on cardiovascular system. Studies show the 
peak action on systolic BP is around 20 minutes after i.v. administration of dexmedetomidine.  
    Post operative   decrease in mean systolic blood pressure in Group B  and group A was 
statistically not significant.  The change in mean diastolic blood pressure between two groups  
was not statistically significant both intra operatively and post operatively.   
.  Hence we conclude from our observations that All the children in the study were 
hemodynamically stable during surgery and 24 hours after.  None of the children had 
bradycardia or hypotension requiring intervention.  . This is supported by Hennaway et al, vijay 
G et al and Saadway et al  they found no clinically significant hemodynamic changes in their 
study52,53,54,55,57.  
   Intraoperatively oxygenation was maintained with 50% oxygen with nitrous oxide.there was no 
fall in saturation in either group. Post operatively spo2 was  above 97% in all patients in room air 
none of them required oxygen supplementation. And hence there was no incidence of respiratory 
depression in  plain bupivacaine or dexmedetomidine group. This finding is similar to other 
studies like Hennaway et al, Saadaway et al, Mousumi neogi ET al.  
Incidentally we noticed occurrence of side effects like shivering, and nausea vomiting. 20% of 
children in group A had shivering whereas in group B only 1 (2%) child had shivering. 
The lesser incidence of shivering in group B is due to dexmedetomidine ( Sukhminder 
singh et al )66 action on thermoregulatory centre in the hypothalamus, which sets the core 
temperature and increases threshold for shivering.   
 The incidence of nausea and vomiting was not statistically different in both groups. In group A 2 
patients had nausea and one patient had vomiting which was treated with injection 
ondonsetron 0.06 mg/kg. In group B one child had vomiting and the one patient had 
nausea.   
    
         From   above observations and comparisions we conclude that the addition of 
dexmedetomidine 2mcg/kg  to caudal 0.25%  bupivacaine 1ml/kg significantly increases 
duration of post‐operative analgesia in children of 2‐7 years age undergoing elective sub 
umbilical surgeries. Addition of dexmedetomidine provides stable hemodynamics and lesser 
incidence of shivering  in patients. The incidence of side effects are not increased  on adding 
dxmedetomidine to caudal bupivacaine. 
 
        
SUMMARY:   
      Bupivacaine is a long acting amide local anesthetic. It  is  most frequently used  
for caudal anaesthesia in children that provides effective analgesia and motor 
blockade. 
 Dexmedetomidine is a potent alpha 2 agonist, widely used to provide analgesia 
sedation and anxiolysis. It is a safe  adjuvant to to bupivacaine in pediatric caudal 
anaesthesia.   
              In our  study we evaluated the effect of combination of bupivacaine and 
dexmedetomidine in   prolongation of post operative analgesia in children. 
Incidentally hemodynamic changes and  side effects like nausea vomiting and 
shivering was also compared between plain bupivacaine  group and combination of 
bupivacaine and dexmedetomidine group,   in children undergoing lower 
abdominal  and perineal surgeries.  
In  a double-blinded comparative study, 100 children aged 2-7 years of ASA 
I and II physical status were randomly allocated to receive a single pre-surgical 
caudal injection of 1ml/kg of  0.25% bupivacaine  and 1ml normal saline  (Group 
A) or 0.25% Bupivacaine and     1ml of 2mcg/kg dexmedetomidine  (Group B),  
after induction of general anaesthesia. Apart from monitoring the vital parameters 
likr,  heart rate, blood pressure, spo2,  all children were assessed for postoperative 
analgesia by FLACC pain scale.  Incidence of side effects like nausea vomiting 
and shivering was noted. 
    The two groups were comparable for age, sex, weight,  vital signs, 
duration and type of surgery. The  following results were noted at the end of study.  
1. Thequality and duration of analgesia was significantly prolonged in group 
B(14+/-69 HOURS) compared to group A (4.22 hour).   
2.Total number of analgesic administered after rescue analgesia  in group A 
was very high compared to group B. 
3, hemodynamic changes between two groups were not significant in both 
groups. There was no bradycardia or hypotension either intra operatively or post 
operatively. 
4.  Incidence of shivering was high in group A compared to group B.  
From above results we conclude that  dexmedetomidine is a safe and 
effective adjuvant to local anaesthetic bupivacaine for paediatric caudal 
anaesthesia. Dexmedetomidine 2mcg/kg with  bupivacaine  0.25%  1ml/kg 
provided  quality  analgesia and  extended  duration of post operative analgesia 
compared  to plain  bupivacaine 0.25%  in equal volumes and concentration when 
administered for caudal block for sub-umbilical surgeries. Dexmedetomidine 
provided hemodynamic stability and less incidence of shivering  in the post 
operative period compared to plain bupivacaine.   
 
 
 
 
 
 
    
 
 
 
   CONCLUSION:   
              From  above observations,   our study allow us to conclude  that  the addition 
of dexmedetomidine 2mcg/kg  to caudal 0.25%  bupivacaine  significantly 
increases duration of post-operative analgesia in children of 2-7 years age 
undergoing elective sub umbilical surgeries. Addition of dexmedetomidine 
provides  stable hemodynamics and lesser incidence of shivering  in paediatric 
patients.   
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PROFORMA         
•                                                           DATE:                                                                      
SERIALNO: 
• NAME:          
• GROUP  A/B :                                  
• AGE/SEX:                              WEIGHT:                                                  IP.NO: 
• DIAGNOSIS:               
• SURGERY PLANNED:     
• ASA STATUS:  
• ASSOCIATED MEDICAL CONDITIONS:  
• PREMEDICATION:       
• IV  ACCESS:  
• MONITORS:                            HR:                              BP:                                   SPO2     
• CAUDAL BLOCK TIME:       
• VOLUME OF LOCAL ANAESTHETIC:  
• INCISION TIME(ONSET TIME):  
 
•  INTRA OPERATIVE MONITORING  
 
Time in 
minutes 
Basal  Intubation  Caudal  10  20  30  40  50 
PR                 
BP                 
SPO2                 
 
 
   POST OP MONITORING   
TIME 
in 
minute 
15  30  45  60  75  90  120  150  180  4  6  8  10  12  24 
HR                               
SBP                               
DBP                               
SPo2                               
 
 
 
FLACC PAIN SCORING for post op monitoring 
  
• TIME OF FIRST RESCUE ANALGESIC DRUG ADMINISTRATION:FLACC score 
>4:  injection fentanyl 1mcg/kg i.v. To achieve score <3  
•  ANY ADDITIONAL ANALGESIC REQUIRED:  
• Incidence of shivering, nausea, vomiting 
                TOTAL DOSE OF ANALGESIC REQUIRED  
               INCIDENCE OF HYPOTENSION AND OR BRADYCARDIA NEEDING 
INTERVENTION 
 
 
 
